ProfileGDS4132 / 215636_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 38% 40% 33% 31% 36% 45% 31% 36% 28% 27% 29% 29% 21% 34% 19% 26% 22% 31% 32% 30% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10196.977738
GSM201543Muscle PCOS pioglitazone 12194.692940
GSM201544Muscle PCOS pioglitazone 16185.686133
GSM201545Muscle PCOS pioglitazone 20185.426331
GSM201829Muscle PCOS pioglitazone 23198.303536
GSM201830Muscle PCOS pioglitazon 251123.5445
GSM201831Muscle PCOS pioglitazone 27175.391631
GSM201832Muscle PCOS pioglitazone 3191.344636
GSM201833Muscle PCOS pioglitazone 4165.496128
GSM201834Muscle PCOS pioglitazone 8163.999627
GSM201835Muscle PCOS after pioglitazone 10256.160729
GSM201836Muscle PCOS after pioglitazone 12260.350929
GSM201837Muscle PCOS after pioglitazone 16236.768121
GSM201838Muscle PCOS after pioglitazone 20275.763534
GSM201839Muscle PCOS after pioglitazone 23238.114419
GSM201840Muscle PCOS after pioglitazone 25258.286526
GSM201841Muscle PCOS after pioglitazone 27239.444922
GSM201842Muscle PCOS after pioglitazone 3262.096631
GSM201843Muscle PCOS after pioglitazone 4276.733132
GSM201844Muscle PCOS after pioglitazone 8267.108730